Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robotic bed promises speedier recovery after heart surgery

NCT ID NCT07273669

Symptom relief Sponsor: University of Salerno Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a special robotic bed called LOLE.K to see if it helps people recover faster after heart valve surgery. Twenty patients aged 60 to 85 will use the bed for early rehabilitation. Researchers will measure how long they stay in the hospital, how quickly they get off breathing machines, and how well they feel physically and emotionally. The goal is to see if the bed improves recovery compared to standard physical therapy.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
robotic bed (LOLE.K)
What this could lead to
If it works, this robotic bed could help heart surgery patients recover faster, with shorter hospital stays and better physical and mental well-being.
What could go wrong
This is a very small early study with only 20 people, so results may not apply to everyone. The bed is a device, not a drug, so benefits may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * patients undergoing aortic and mitral vale surgery * patients aged between 60 and 85 Exclusion Criteria: * Age \< 18 years old * inability to provide informed consent, either verbally or in writing, or unwillingness to participate in systematic follow-up * Life expectancy \< 1 year * Recent myocardial infarction (MI) with ST segment elevation (\< 72 hours) * Left ventricular ejection fraction \< 30% * Clearance della creatinina \< 30 ml/min. Further exclusion criteria included bed rest orders, patients in a palliative care setting or with therapy limitations. Restrictions due to the device were height outside the ranfe of 190cm, weight outside the range of 115kg, pacemakers, other electrical stimulators, or implanted medical pumps.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Aortic valve diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Aortic Valve Disease aortic valve disorder mitral valve insufficiency

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Aortic valve diseases Mitral valve failure

Contacts and locations

Locations

  • AOU San Giovanni di Dio e Ruggi d'Aragona

    Salerno, Campani, 84131, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.